Skip to content
2000
Volume 20, Issue 33
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

In the past 50 years, thalidomide has undergone a remarkable metamorphosis from a notorious drug inducing birth defects into a highly effective therapy for treating leprosy and multiple myeloma. Today, most notably, thalidomide and its analogs have shown efficacy against a wide variety of diseases, including inflammation and cancer. The mechanism underlying its teratogenicity as well as its anticancer activities has been intensively studied. This review summarizes the biological effects and therapeutic uses of thalidomide and its analogs, and the underlying mechanisms of thalidomide’s action with a focus on its suppression of tumor growth.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/09298673113209990198
2013-11-01
2024-11-16
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/09298673113209990198
Loading

  • Article Type:
    Research Article
Keyword(s): angiogenesis; cancer; multiple myeloma; teratogenesis; Thalidomide
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test